Dupilumab reduces exacerbations and improves lung function in uncontrolled, moderate-to-severe asthma patients across prior historical exacerbation subgroups in the phase 3 LIBERTY ASTHMA QUEST study

被引：0
|
作者：
Ford, L. [1 ]
Corren, J. [2 ]
Kuna, P. [3 ]
Dong, Q. [4 ]
Staudinger, H. [5 ]
Maroni, J. [6 ]
Rowe, P. [5 ]
Amin, N. [6 ]
Pirozzi, G. [5 ]
Ruddy, M. [6 ]
Akinlade, B. [6 ]
Graham, N. M. H. [6 ]
Teper, A. [5 ]
机构：
[1] Ctr Asthma & Allergy, Bellevue, WA USA
[2] Ronald Reagan UCLA Med Ctr, Santa Monica, CA USA
[3] Med Univ Lodz, Lodz, Poland
[4] Sanofi Genzyme, Cambridge, England
[5] Sanofi, Bridgewater, MA USA
[6] Regeneron Pharmaceut Inc, Tarrytown, NY USA
来源：
ALLERGY | 2018年 / 73卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
0854
引用
收藏
页码：464 / 465
页数：2
相关论文
共 50 条
  • [1] DUPILUMAB REDUCES EXACERBATIONS AND IMPROVES LUNG FUNCTION IN UNCONTROLLED, MODERATE-TO-SEVERE ASTHMA PATIENTS REGARDLESS OF PRIOR EXACERBATION HISTORY IN THE PHASE 3 LIBERTY ASTHMA QUEST STUDY
    Pavord, I.
    Ford, L. B.
    Corren, J.
    Kuna, P.
    Dong, Q.
    Staudinger, H.
    Maroni, J.
    Rowe, P.
    Rout, R.
    Amin, N.
    Akinlade, B.
    Graham, N. M. H.
    Teper, A.
    THORAX, 2018, 73 : A121 - A122
  • [2] DUPILUMAB REDUCES SEVERE EXACERBATION RATE AND IMPROVES LUNG FUNCTION IN ADOLESCENT PATIENTS WITH UNCONTROLLED, MODERATE-TO-SEVERE ASTHMA: FROM THE LIBERTY ASTHMA QUEST STUDY
    Maspero, Jorge
    Fitzgerald, Mark
    Pavord, Ian
    Wenzel, Sally
    Zhang, Bingzhi
    Maroni, Jaman
    Rowe, Paul
    Amin, Nikhil
    Pirozzi, Gianluca
    Ruddy, Marcella
    Akinlade, Bolanle
    Graham, Neil
    Teper, Ariel
    CHEST, 2018, 154 (04) : 25A - 27A
  • [3] Dupilumab Reduces Severe Exacerbations and Improves Lung Function in Late-Onset, Uncontrolled, Moderate-to-Severe Asthma Patients Enrolled in the LIBERTY ASTHMA QUEST Study
    Hanania, N. A.
    Bateman, E. D.
    Castro, M.
    Pavord, I. D.
    Papi, A.
    FitzGerald, J. M.
    Maspero, J. F.
    Katelaris, C.
    Singh, D.
    Rice, M. S.
    Rowe, P.
    Lu, Y.
    Amin, N.
    Staudinger, H. W.
    Graham, N. M. H.
    Teper, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [4] Dupilumab Reduces Severe Exacerbations and Improves Lung Function Regardless of Baseline Bronchodilator Reversibility in Patients with Uncontrolled Moderate-to-Severe Asthma Enrolled in the LIBERTY ASTHMA QUEST Study
    Pavord, I.
    Castro, M.
    Rabe, K. F.
    Hanania, N. A.
    Papi, A.
    FitzGerald, J. M.
    Rice, M. S.
    Rowe, P.
    Lu, Y.
    Amin, N.
    Staudinger, H. W.
    Graham, N. M. H.
    Teper, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [5] Dupilumab Improves Lung Function and Reduces Severe Exacerbation Rate in Patients With Uncontrolled, Moderate-to-Severe Asthma With or Without Comorbid Allergic Rhinitis: Results From the Phase 3 LIBERTY ASTHMA QUEST Study
    Busse, William W.
    Maspero, Jorge F.
    Hanania, Nicola A.
    Fitz-Gerald, J. Mark
    Ford, Linda B.
    Rice, Megan
    Lu, Yufang
    Rowe, Paul
    Staudinger, Heribert
    Amin, Nikhil
    Ruddy, Marcella
    Graham, Neil M. H.
    Teper, Ariel
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2019, 143 (02) : AB97 - AB97
  • [6] Dupilumab Improved Lung Function in Patients with Uncontrolled, Moderate-to-Severe Asthma Despite Exacerbation Events During the LIBERTY ASTHMA QUEST Study
    Rabe, K. F.
    Castro, M.
    Wenzel, S. E.
    Corren, J.
    Pavord, I. D.
    Katelaris, C.
    Tohda, Y.
    Rice, M. S.
    Lu, Y.
    Rowe, P.
    Staudinger, H. W.
    Amin, N.
    Akinlade, B.
    Graham, N. M. H.
    Teper, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [7] DUPILUMAB REDUCES SEVERE ASTHMA EXACERBATION RATES AND IMPROVES LUNG FUNCTION ACROSS A RANGE OF PRIOR EXACERBATIONS IN PATIENTS WITH ELEVATED TYPE 2 BIOMARKERS: THE LIBERTY ASTHMA QUEST STUDY
    Katelaris, Constance H.
    Douglass, Jo A.
    Ford, Linda B.
    Rice, Megan S.
    Moody, Jana
    Djandji, Michel
    Radwan, Amr
    Rowe, Paul
    Deniz, Yamo
    Amin, Nikhil
    Teper, Ariel
    INTERNAL MEDICINE JOURNAL, 2019, 49 : 34 - 35
  • [8] DUPILUMAB EFFICACY IN UNCONTROLLED, MODERATE-TO-SEVERE ALLERGIC ASTHMA IN THE PHASE 3 LIBERTY ASTHMA QUEST STUDY
    Castro, M.
    Corren, J.
    Hanania, N.
    Pavord, I.
    Quirce, S.
    Thangavelu, K.
    Rice, M.
    O'Riordan, T.
    Maroni, J.
    Rowe, P.
    Lu, Y.
    Amin, N.
    Ruddy, M.
    Akinlade, B.
    Graham, N.
    Teper, A.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2018, 121 (05) : S8 - S8
  • [9] Dupilumab Improves Lung Function in Children With Uncontrolled, Moderate-to-Severe Asthma: LIBERTY ASTHMA VOYAGE
    Bacharier, B. L.
    Guilbert, W. T.
    Katelaris, H. C.
    Deschildre, A.
    Liu, D.
    Mannent, P. L.
    Amin, N.
    Laws, E.
    Ruddy, M.
    Ortiz, B.
    Jacob-Nara, A. J.
    Deniz, Y.
    Rowe, J. P.
    Atenhan, A.
    Thakur, M.
    Lederer, J. D.
    Hardin, M.
    PNEUMOLOGIE, 2022, 76 : S40 - S40
  • [10] Dupilumab Improves Lung Function in Children with Uncontrolled, Moderate-to-Severe Asthma: LIBERTY ASTHMA VOYAGE
    Bacharier, L. B.
    Guilbert, T. W.
    Katelaris, C. G.
    Deschildre, A.
    Liu, D.
    Mannent, L. P.
    Laws, E.
    Ruddy, M.
    Jacob-Nara, J. A.
    Deniz, Y.
    Rowe, P. J.
    Lederer, D. J.
    Hardin, M.
    PEDIATRIC PULMONOLOGY, 2022, 57 : S97 - S98
12345